Loading clinical trials...
Loading clinical trials...
Systemic chemotherapy with cytotoxic drug is of limited effectiveness in advanced pancreatic cancer patients. Gemcitabine has been used as the first-line drug for advance pancreatic cancer for over tw...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Air Force Military Medical University, China
NCT07198659 · Unresectable Pancreatic Cancer
NCT06135896 · Unresectable Pancreatic Cancer, Unresectable Bile Duct Carcinoma, and more
NCT06099119 · Unresectable Pancreatic Cancer
NCT04789486 · Non-small Cell Lung Cancer, Advanced Pancreatic Adenocarcinoma, and more
NCT06278454 · Unresectable Pancreatic Cancer
Xijing Hospital of Digestive Diseases, Fourth Military Medical University
Xi'an, Shaanxi
Xijing Hospital of Digestive Diseases, Fourth Military Medical University
Xi'an, Shaanxi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions